Weaning of Immunosuppression in Nephritis of Lupus
Status:
Active, not recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The investigators wish to evaluate the discontinuation of maintenance immunosuppressive
treatment after 2 years in patients with stable remission after a proliferative lupus
nephritis. The patients will be continuing their treatment with hydroxychloroquine, possibly
associated with low dose corticosteroids.